Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Creative Diagnostics Introduces Treponema Pallidum Antigens

Creative Diagnostics
Posted on: 07 Nov 17
Creative Diagnostics Introduces Treponema Pallidum Antigens

As a leading supplier of research products and custom services to global academic, pharmaceutical and biotech communities, Creative Diagnostics has introduced new treponema pallidum antigens for the diagnosis of syphilis, including recombinant T. Pallidum TpN47, T. Pallidum Major Membrane Immunogen p15 and T. pallidum Tp0453 antigens, etc. These products are intended for research and manufacturing uses only. It is suggested that the antigen be stored in use size aliquots and thawed just prior to use.

Treponema pallidum is the causative pathogen of syphilis. Treponema pallidum are slender bacteria, which is 5-20 µm long and 0.2 µm wide; they feature 10-20 primary windings and move by rotating around their lengthwise axis. Syphilis affects only humans. The disease is normally transmitted by direct contact, in most cases during sexual intercourse. Infection comes about because of direct contact with lesions containing the pathogens, which then invade the host through microtraumata in skin or mucosa. The incubation period is two to four weeks. The disease progresses in several stages designated as primary, secondary and tertiary syphilis or stages I, II and III.

"Creative Diagnostics continues to strengthen its product offerings by supplying such quality antigen products and delivering outstanding customer service to the world marketplace. These new treponema pallidum antigens and related services will further expand the choices and opportunities available to our customers worldwide." said Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics. "We’ll make sure that customers have access to these new products, and look forward to expanding their study capabilities to support advancements in disease research."

"We understand that antigens are of critical importance to the disease research for the global research community," expressed Dr. Randy S. Vaughn, senior researcher, Creative Diagnostics. "We’re glad to support global life science research customers that aim to understand disease development and to help contribute to advancements in medical research for Syphilis by enabling the development of new tools."

If you need a antigen that meets the sensitivity and specificity demands required in your projects, please contact Creative Diagnostics at 1-631-619-7922 or email to contact@creative-diagnostics.com.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. It also provides contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers’ assay development and manufacturing needs.

For more information:
www.creative-diagnostics.com/tag-treponema-pallidum-antigens-74.htm

Editor's Details

Thomas Schmitt
Creative Diagnostics
www.creative-diagnostics.com
16316197922
contact@creative-diagnostics.com

Last updated on: 07/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.